Eldoes Tablet (Erdosteine)

Adult dose

Adults: Administer (take) 300 mg of erdosteine orally 2–3 times daily. When used for acute respiratory diseases, do not administer continuously for more than 10 days.

This medicine should not be administered to certain patients. First, patients who have an allergic reaction to this medicine or its ingredients should not take it. Patients with liver cirrhosis or cystathionine synthase deficiency should avoid this medicine, as its metabolites may interfere with methionine metabolism. Patients with peptic ulcers should also be cautious as their symptoms might worsen. Patients with severe kidney impairment, particularly those with a creatinine clearance of less than 25 mL/min, should not take this medicine. Severe liver impairment patients are also prohibited from using this medicine. Additionally, this medicine contains lactose, so patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. Patients with mild to moderate liver impairment should use this medicine cautiously and should not exceed 300 mg per day. Patients with diabetes or those on calorie-restricted diets need to be particularly careful when using this medicine in syrup form. In case of overdose, symptoms such as excessive sweating, dizziness, and facial flushing may occur. Gastrointestinal symptoms such as headache, cold symptoms, difficulty breathing, taste disturbances, nausea, vomiting, diarrhea, abdominal pain, and heartburn may also arise. Skin symptoms such as urticaria, red spots, and eczema may appear. Some patients have reported symptoms such as fatigue, dyspepsia, palpitations, facial or generalized swelling, itching, weakness, lethargy, and rashes, but the direct association with this medicine is not clear. When taking this medicine with expectorants, it may become difficult to expel phlegm due to the suppression of cough, increasing the risk of bronchial infections and causing issues with bronchial contraction and relaxation, so extra caution is advised when taken together. Pregnant or potentially pregnant women, as well as breastfeeding women, are advised not to take this medicine because its safety has not been sufficiently confirmed.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste alteration
• nausea
• vomiting
• diarrhea

Drug interactions

This medicine should be taken in consultation with a doctor or pharmacist when taken with cough medicines.

This medicine should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. This helps maintain the efficacy of the medication and prevents deterioration.

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle